later, the sera from such animals were passed over a BPO-BGG-bearing polyacrylamide immunoadsorbent column prepared as previously described (3) . The anti-BPO-BGG antibodies bound to the column were eluted with glycine-HC1 buffer, 0.1 M, pH 2.5, containing 0.9% NaC1 and the eluate neutralized with 1 M Tris. Antibody concentration was determined by the absorbance at 278 nm in neutral solution using an extinction coefficient (E~:m) of 14.0 as described by Eisen et al. (4) for anti-DNP antibodies.
The immune anti-BPO-BGG antibodies were then used as immunogens for the sensitization of four strain 2 and four strain 13 guinea pigs. Two strain 2 guinea pigs received 2 mg of anti-BPO-BGG (raised in strain 2) and the other two strain 2 animals were given the same amount of anti-BPO-BGG derived from strain 13 animals. Similarly, two strain 13 guinea pigs received swain 2 anti-BPO-BGG while two other strain 13 animals were immunized with anti-BPO-BGG raised in strain 13 guinea pigs. The anti-BPO-BGG was injected in 0.8 ml CFA, equally distributed among the four foot pads. 2 wk later the animals received a boost of 1 mg of anti-BPO-BGG in CFA (subcutaneously in multiple sites in the nuchal skin) and a further injection (200 tzg anti-BPO-BGG intradermally) 10 days after the first boost. All animals were exsanguinated 2 wk after the last injection, the sera sterilized by Millipore filtration, and stored at -20°C.
Cytotoxicity Testing. The details of this test have previously been reported (1) . The percentage of maximum '~Cr released was calculated as follows:
Radioactivity released by antiserum dilution ~Cr release % = 100 × -radioactivity released in absence of antiserum Radioactivity released by frozen-thawed cells -radioactivity released in absence of antiserum.
Absorption ofAnti-ldiotypic Antisera. Antisera were mixed with an equal volume of packed lymph node and spleen cells (approximately I0 ' cells/ml of serum) for 4 h at 4°C. Each antiserum was absorbed at least three times. The absorbed antisera were centrifuged at 10,000 rpm for 30 rain and sterilized by Millipore filtration.
Cell Preparation
LYMPH NODE CZLLS. The regional lymph nodes were removed, freed as far as possible from fat, and cell suspensions prepared by teasing with scissors and forceps and then by pressing the lymph node fragments through no. 60 wire screens (Haska, Bern, Switzerland). The cell suspensions were then washed twice with medium 199 (M-199) . The cell population was composed of over 95% lymphocytes and about 5% macrophages. For the assay of antigen-induced lymphocyte proliferation in the presence of alloantisera, lymphocyte suspensions (20 x 10~/ml) were incubated with either 100 ~g of DNPT-GL and GT or 400/zg of aspiryl-ovalbumin (ASP-OVA), BPO-BGG, and (T,G)-A--L/ml of M-199 containing 10% heat-inactivated fetal calf serum. A portion of the cells was also incubated with 10 /zg phytohemagglutinin (PHA)/ml of M-199. The cells were pulsed with antigen for 30 min at 37°C. Since ASAN is insoluble in water, ASP-OVA prepared as previously described by de Weck (5) was used in the in vitro studies. The cells were washed three times with M-199 and then cultured at a cell concentration of 2 × 10 ~ cells/ml in polystyrene tubes (Nunc, Roskilde, Denmark) at 37°C for 72 h, adding either I% normal guinea pig serum or 1% guinea pig antiserum supplemented with 9% heat-inactivated fetal calf serum. 18 h before the termination of the cultures, 1 pCi of tritiated thymidine (sp act, 5 Ci/mmol; The Radiochemical Centre, Amersham, Great Britain) was added to each vial. The cells were harvested with a multiple cell culture harvester (Skatron, Lierbyen, Norway), and the radioactivity was measured in a Beckman liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.). The results were expressed as total counts per minute per culture.
PERITONEAL EXUDATE LYMPHOCYTES (PEL). Guinea pigs were injected intraperitoneally with 30 ml of sterile paraffin oil to induce a peritoneal exudate. 4 days later, the animals were killed by cardiac puncture and the peritoneal cavity washed with 200 ml of Hanks' balanced salt solution containing 5 U/ml of preservative-free heparin (Hoffmann-La Roche, Basel, Switzerland). Peritoneal exudate cells were washed three times in Hanks' solution to remove oil and finally suspended in RPMI 1640 (Microbiological Associates, Bethesda, Md.) containing 100 U penicillin and 100 ~g of streptomycin/ml and 2 mM glutamine. The lymphocytes were separated from the whole exudate cell population by passage over a column of cotton wool (Schaffhauser Watte, Schaffhausen, Switzerland) packed loosely in a 50 ml plastic syringe. The population of cells after column purification consisted of 80-90% lymphocytes with a viability of over 95% as measured by trypan blue exclusion. About 90% of the PEL formed rosettes with rabbit red blood cells as previously described (1, 3) . The assay of antigen-induced proliferation in the presence of antisera was the same as described for lymph node cells. Radioimmunoassay. Untreated Sepharose 4B and activated Sepharose bearing a normal guinea pig Ig fraction or Ig fractions prepared from strain 2 antistrain 2 anti-BPO-BGG (a strain 2 BPO-BGG) and strain 13 antistrain 13 anti-BPO-BGG (~ strain 13 BPO-BGG) sera, were equilibrated with Phadebas RAST buffer solution, pH 7.4 (Pharmacia Fine Chemicals, Ltd.), containing 2 ml Tween 20/100 ml buffer for 2 h before use. 100 t~l of Sepharose (100 mg wet weight) were incubated with 5 ~g of J2'~I-labeled antigen (Ig fractions of strain 2 and strain 13 anti-BPO-BGG were labeled with iodine-125 according to the method of Hunter and Greenwood (6), in 100 t~l RAST buffer solution in the presence of PBS or unlabeled antigen (5 t~g in 100 ill PBS) for 16 h at room temperature. The Sepharose was then washed 10 times with 0.9% NaC1 (containing 5 ml Tween 20/liter) and the radioactivity bound to the Sepharose beads determined in a LKB 8000 gamma counter (LKB Produkter, Stockholm, Sweden).
Preparation of Sepharose
Sephadex Chromatography. 2 ml of antiserum (~ strain 2 BPO-BGG and a strain 13 BPO-BGG) were chromatographed on Sephadex G-200 (90 x 2.6 cm) which had been equilibrated with TBS. The peak tubes from the 19S, 7S, and 4S regions were tested for their capacity to inhibit antigen-induced lymphocyte proliferation.
Results
Relationship between Histocompatibility Type and Responsiveness to Antigens. We have previously shown (1) that strain 13 and (2 x 13)F1 guinea pigs respond to low doses of ASAN, BPO-BGG, and (T,G)-A--L (as assessed by delayed skin reactivity and in vitro lymphocyte stimulation), whereas strain 2 animals fail to respond. However upon stronger and more prolonged immunogenic stimuli [i.e. immunization with 10-to 20-fold higher doses ofASAN, BPO-BGG, and (T,G)-A--L than that required for strain 13 animals] strain 2 animals can also be sensitized to these three antigens. In the present study we immunized strain 2 and strain 13 animals with high doses of ASAN, BPO-BGG, and (T,G)-A--L to ensure that all strain 2 animals would give strong delayed skin responses when tested with these antigens 3 wk after immunization. In addition, all strain 2 animals responded to DNP-GL but not to GT, whereas strain 13 guinea pigs showed strong delayed skin reactivity to GT but failed to react to DNP-GL; (2 x 13)F1 responded to both GT and DNP-GL. Responsiveness to DNP-GL and GT is known to be linked to the strain 2 and strain 13 haplotype, respectively (7, 8) .
Inhibition of Lymphocyte Stimulation by Anti-Idiotypic Antisera Raised in
Strain 2 and Strain 13 Guinea Pigs. As described in the Material and Methods and Fig. 1 , antisera were raised in strain 2 and 13 guinea pigs using as antigen anti-BPO-BGG antibodies from strain 2 or 13, purified by immunoadsorption on polyacrylamide columns bearing BPO-BGG. The following four antisera were investigated for their ability to inhibit antigen-induced lymphocyte proliferation: ~ strain 2 BPO-BGG, ~ strain 13 BPO-BGG, strain 2 antistrain 13 anti-BPO-BGG, and strain 13 antistrain 2 anti-BPO-BGG. The first two antisera, presumed to be directed against strain 2 and strain 13 anti-idiotypes, were designated as ~. None of the four sera appeared to contain lymphocytotoxic antibodies to currently known alloantigens coded for by the B and I regions of the guinea pig MHC, as determined by the slCr-release assay on strain 13 and strain 2 lymphocytes (results not shown). Table I Table I. response is suppressed as well as the proliferative responses of cells stimulated with ASP-OVA, BPO-BGG, and (T,G)-A--L (7, 9). By contrast, anti-RBpo-aGC serum (raised by immunizing with lymphoid cells among (2 x 13)F2 hybrid guinea pigs), ~ strain 2 BPO-BGG as well as ~ strain 13 BPO-BGG sera totally suppress the proliferative response only of BPO-BGG-pulsed cells but do not affect the response to any of the other antigens. On the other hand, antisera raised in strain 2 and strain 13 guinea pigs against anti-BPO-BGG antibody of the allogeneic strain (i.e., strain 2 antistrain 13 anti-BPO-BGG and strain 13 antistrain 2 anti-BPO-BGG) failed to interfere with the in vitro reactivity induced by any of the antigens. In contrast to the situation with 2 × 13 lymphoid cells from high doseimmunized animals, cells from low dose-immunized animals can only be inhibited by ~ strain 13 BPO-BGG serum but not by ~ strain 2 BPO-BGG (Table II) suggesting that high dose immunization is required to induce the synthesis of the appropriate strain 2-specific idiotype recognition structures on the membrane of primed (2 x 13)F1 cells.
The Failure of d Strain 2 BPO-BGG and d Strain 13 BPO-BGG Sera to Suppress Lymphocyte Activation of Cells Derived from the Allogeneic
Strain. To investigate the possibility that the ~ strain 2 BPO-BGG and strain 13 BPO-BGG sera may be directed against strain-specific idiotypes, the capacity of these antisera to inhibit T-cell activation in the syngeneic and allogeneic strain was studied. Furthermore, to ensure that the stimulation observed in this system was due to tritiated thymidine incorporation into the DNA ofT cells, the influence of the antisera on PEL (which are composed almost entirely of thymus-derived cells [10] ) from primed strain 2 and strain 13 guinea pigs was also investigated.
The data in Table III demonstrate that anti-RBpo-BCG fails to inhibit BPO- * See footnote to Table I. BGG-induced T-cell proliferation of strain 2 cells which are capable of responding to all three antigens. Antiserum ~ strain 13 BPO-BGG also does not suppress the in vitro BPO-BGG response. By contrast, the corresponding antiserum strain 2 BPO-BGG specifically suppresses T-cell activation of BPO-BGG-pulsed immune strain 2 cells. In addition, immune BPO-BGG ÷ cells from strain 2 guinea pigs are capable of absorbing the inhibitory activity from ~ strain 2 BPO-BGG serum, while immune BPO-BGG ÷ cells from strain 13 animals fail to do so. By contrast, cells from nonimmunized animals failed to absorb the inhibitory activity from the two strain-specific antisera (results not shown).
Conversely, BPO-BGG-pulsed PEL from primed strain 13 guinea pigs can only be inhibited by an antiserum against anti-BPO-BGG raised in the isogeneic strain (~ strain 13 BPO-BGG) but not by ~ strain 2 BPO-BGG, raised in the allogeneic strain (Table IV) . In addition, anti-RBpo-B~c can also suppress the BPO-BGG response of strain 13 but not of strain 2 cells. It is clear, therefore, that the antisera (~ strain 2 BPO-BGG and ~ strain 13 BPO-BGG) must interact with some gene product(s) characteristic of the isogeneic strain in order to suppress antigen-induced T-cell proliferation in vitro. It seems likely that the antisera are directed against membrane-associated strain-specific immunoglobulin idiotypes which may function as T-cell antigen receptors.
The Inhibitory Activity of d Strain 13 BPO-BGG Can Only Be Absorbed by BPO-BGG ÷ Cells.
In addition to strain specificity, the anti-idiotypic serum, raised in a strain 13 combination against "receptors" for BPO-BGG, is specific for BPO-BGG-pulsed cells and does not suppress either ASP-OVA-or (T,G)-A--L-induced lymphocyte proliferation (Tables I, III , and IV). The data in Table V lend further support to the specificity of the antiserum: inhibitory activity can only be removed by absorption with cells from strain 13 guinea pigs which respond to low doses of BPO-BGG and not by cells from the occasional strain 13 animals which fail to respond to BPO-BGG but give strong responses to ASAN and (T,G)-A--L.
The Inhibitory Activity of the Anti-Idiotypic Sera is Associated with the 19S Fraction. 2 ml of ~ strain 13 BPO-BGG serum were chromatographed on Sephadex G-200, and the fractions eluted with TBS. The peak tubes from the 19S, 7S, and 4S fractions were tested for their capacity to inhibit BPO-BGGinduced lymphocyte proliferation.
The antigen-pulsed cells were incubated with 1% normal guinea pig serum and 9% heat-inactivated fetal calf serum together with either 0.1 ml of TBS or 0.1 ml of the appropriate 19S, 7S, or 4S Sephadex G200 column fractions. The absorbances at 278 nm of the peak tubes of the various fractions were as follows: 1.1 (19S); 0.7 (7S); and 1.0 (4S).
The data in Table VI show that the undiluted 19S fraction of ~ strain 13 BPO-BGG totally inhibits the in vitro BPO-BGG response but does not affect (T,G)-A--L-induced in vitro proliferation. The 7S and 4S fraction, on the other hand, suppress BPO-BGG reactivity by only 30%. At a 1/20 dilution only the 19S fraction inhibits the in vitro BPO-BGG response. It appears, therefore, that the inhibitory activity of the anti-idiotypic serum is primarily associated with the 19S fraction. Similar data were obtained with a strain 2 BPO-BGG which had been chromatographed on Sephadex G-200 (results not shown). 13 guinea pigs, which had been immunized with either strain 2 or strain 13 anti-BPO-BGG, failed to form precipitating antibodies as detected by double diffusion in 1% Ionagar no. 2 (Difco Laboratories) even when the antisera were concentrated up to 10-fold and tested against a wide range of antigen (anti-BPO-BGG) concentrations. Furthermore, none of the antisera formed a precipitin line with BPO-BGG suggesting that no more than 0.1/~g of BPO-BGG (a quantity of BPO-BGG which when injected in CFA induces precipitating antibodies after 14 days) could have been eluted from the antigen immunoadsorbent column during the preparation of anti-BPO-BGG. Table VII illustrates that strain 2 and strain 13 anti-idiotypic sera bind isogeneic anti-BPO-BGG preferentially to the allogeneic antibody. Furthermore, the binding of isogeneic 125I-labeled anti-BPO-BGG, on the other hand, by the anti-idiotypic serum immunoadsorbents can be inhibited by "cold" isogeneic anti-BPO-BGG to a slightly greater extent than by the allogeneic antibody. By contrast, Sepharose alone or Sepharose bearing 500 ~g of normal guinea pig Ig under these conditions, bind about 7,500 and 12,000 cpm of labeled antibody, respectively.
The Relative Affinity of Strain 2 and Strain 13 Anti-Idiotype Sera for Isogeneic and Allogeneic Anti-BPO-BGG. The antisera raised in strain 2 and strain TABLE VI

The Inhibition of BPO-BGG-Induced Proliferation of Primed Strain 13 Lymph Node Cells by the 19S Fraction of d Strain 13 BPO-BGG Serum
Does the Interaction of d Strain 2 and d Strain 13 BPO-BGG Sera with BPO-BGG-Sensitive Cells Result in the Liberation of Cytotoxic Factors or Immune Complexes which could Inhibit the Proliferation of Cells Sensitive to Another
Antigen? The inhibition of antigen-induced lymphocyte proliferation by antiidiotypic antisera might be visualized as a specific blindfolding of antigen receptors on T cells. However, it is also conceivable that the interaction of antiidiotype antibodies with receptors might lead to the release of cytotoxic factors and/or immune complexes capable of nonspecifically blocking lymphocyte prolif- Table VHI show that the stimulation induced by BPO-BGG and (T,G)-A--L alone is not completely additive (cf. cells pulsed with both antigens simultaneously). However, the results clearly show that a strain 13 and ~ strain 2 BPO-BGG sera do not completely inhibit the proliferation of cells which had been pulsed with both antigens and that stimulation by (T,G)-A--L remains largely intact. This suggests that inhibition of proliferation by anti-idiotypic sera is largely specific and does not involve nonspecific cytotoxic cell products, which may be released from BPO-BGGsensitive cells, upon interaction with anti-idiotypic antibodies and/or antigen. Discussion There is a growing body of evidence that anti-idiotypic antibodies can specifically regulate a number of immunological phenomena such as the suppression (11) (12) (13) or enhancement (14, 15) of antibody production and the specific inhibition of graft-vs.-host (16, 17) and mixed leukocyte culture reactivity (18) . In most instances anti-idiotypic antibodies were raised by allo-(17) or heteroimmunization (14) though the production of autoanti-idiotypic antibodies has also been reported in rabbits (19) . The data presented in this paper clearly demonstrate that anti-idiotypic antibodies raised syngeneically in strain 2 and 13 guinea pigs against anti-BPO-BGG can specifically and markedly suppress in vitro lympho- Table I. cyte proliferation of cells from syngeneic guinea pigs. It is striking that in our system only the syngeneic strain produced an antiserum capable of inhibiting antigen-induced lymphocyte proliferation in that same strain, whereas alloimmunization was ineffective. No evidence was obtained that anti-idiotype or even antiallotype antibodies were produced by immunizing strain 2 animals with anti-BPO-BGG antibodies from strain 13 and vice versa. This would suggest, that strain 2 and 13 (which are closely related) may also share the same immunoglobulin allotypes. On the other hand, our findings also raise the interesting notion that strain 2 and strain 13 guinea pigs are apparently high responders to their own idiotypes but not to the idiotypes of the allogeneic strain. This is consistent with the hypothesis that autoanti-idiotypes play an important role in the regulation of the immune response (20) . We have previously described the preparation of antisera which can specifically block antigeninduced lymphocyte proliferation (1). These antisera were raised by immunizing with lymphoid cells from various (2 × 13)F2 hybrid guinea pigs in which the responsiveness to low doses of ASAN, BPO-BGG, and (T,G)-A--L segregated independently of each other. One of these anti-R sera (anti-RBeo-scc) closely resembles the strain 13 anti-idiotypic serum which has been raised by immunizing strain 13 guinea pigs with immunoadsorbent-purified anti-BPO-BGG antibody. The inhibitory activity of both sera, raised by these two different immunization procedures, can be absorbed by lymphoid cells from immunized strain 13 guinea pigs but not by cells from immunized strain 2 animals. The failure of nonimmunized strain 2 and strain 13 cells to absorb inhibitory activity suggests that immunization with BPO-BGG is necessary to stimulate the proliferation of sufficient clones of cells bearing specific receptors or recognition structures for BPO-BGG. This view would also be consistent with the finding that antigenspecific receptors for phosphorylcholine on the surface of murine spleen cells are demonstrable on the cells of immunized but not of unimmunized animals (21) .
T~LE VII The Relative Affinity of Strain 2 and Strain 13 Anti-Idiotypic Sera for Isogeneic and
The anti-RBpo_acc serum and the strain 13 anti-idiotype serum can specifically inhibit BPO-BGG-induced T-cell stimulation and do not interfere with the in vitro proliferation of ASP-OVA-and (T,G)-A--L-pulsed lymphoid cells. They seem therefore to interact specifically with BPO-BGG-specific lymphocyte receptors. It appears also that these antisera are not directed against gene products which are linked to or part of the 2 or the 13 MHC. Firstly, the antisera were raised either between 2 × 13 siblings (anti-RBeo-Bcc) or between inbred strain 13 guinea pigs which should possess identical MHC. Secondly, neither antiserum inhibits the DNP-GL or GT response in (2 x 13)F~ animals. The immune response to DNP-GL and GT is controlled by autosomal Ir genes linked to the 2 and 13 MHC, respectively (7, 8) . It view of the similarities in activity, specificity, and adsorption properties it is likely that anti-RBpo-Bcc and ~ strain 13 BPO-BGG are both directed against the same set of recognition structures for BPO-BGG on the cell membrane of strain 13 lymphocytes. Whether these recognition structures are represented to the same extent on T or B lymphocytes will have to await immunofluorescence and autoradiographic studies. Preliminary studies indicate that PEL are more efficient than lymph node cells in absorbing inhibitory activity from the anti-idiotypic sera suggesting that these idiotype receptors may be expressed to a greater extent on T rather than on B cells. The observation that the anti-idiotypic antisera inhibited antigen-induced proliferation of a purified T-cell population suggests the presence on T cells of receptors with similar idiotypic specificities to those present on circulating immunoglobulins. This would confirm the findings of Binz and Wigzell obtained with transplantation antigens (17) .
The inhibition of the BPO-BGG-induced response seems to involve an interaction between the antiserum and the appropriate strain-specific idiotype receptors on immune cells, i.e., a kind of blindfolding. The fact that inhibition occurs even after brief pulse with antigen but requires the continuous presence of the antibody during culture (1) is compatible with this interpretation. Furthermore, the failure of the BPO-BGG anti-idiotypic sera to completely inhibit a sensitive cell population which had been pulsed simultaneously with both BPO-BGG and (T,G)-A--L, suggests that the inhibition of BPO-BGG-sensitive cells is largely specific and that cytotoxic cell products or antigen-antibody complexes which may be released by BPO-BGG-sensitive cells are not able to suppress nonspecifically (T,G)-A--L-induced cell proliferation. It may be wondered whether, in addition to anti-idiotypic antibodies, the antisera raised by immunization with purified anti-BPO-BGG antibodies may also contain anti-BPO-BGG antibodies. This could theoretically be the case if BPO-BGG or immune complexes had been eluted from the immunoadsorbent column. However, if the animals, in addition to free anti-BPO-BGG antibody, had been immunized with a small amount of eluted BPO-BGG-antibody complexes, it is difficult to see how the "contaminating" anti-BPO-BGG in the anti-idiotype sera could account for the specific inhibition of BPO-BGG-induced lymphocyte activation. Firstly, no such precipitating anti-BPO-BGG antibodies were detected in the anti-idiotype sera. Secondly, ~i strain 13 BPO-BGG totally inhibits the BPO-BGG response at a final concentration of 1:100, whereas a precipitating anti-BPO-BGG antiserum fails to do so at that concentration (data not shown). Anti-BPO-BGG even at a final concentration of 1:50 has virtually no effect on the PHA and antigen responses in vitro while a strain 13 BPO-BGG at the same concentration totally abolishes antigen responsiveness. Finally, the possible presence of anti-BPO-BGG antibodies could not explain the strain-specific inhibitory effect of the anti-idiotypic antisera. These observations strongly suggest therefore that the anti-BPO-BGG antibodies in the anti-idiotypic sera do not contribute to the inhibitory activity of these sera.
The ability of both strain 2 and strain 13 anti-idiotypic sera to suppress BPO-BGG responsiveness of primed (2 x 13)F1 cells (Table I) could at first glance suggest that, unlike the situation with immunoglobulin allotypes which frequently appear to display allelic exclusion (22, 23) , both allelic forms of the BPO-BGG-specific immunoglobulin idiotypes could be expressed on F1 lymphoid cells. However, this possibility holds for primed (2 × 13)F~ cells immunized with high doses of antigen (Table II) . By contrast, (2 x 13)F1 cells primed with low doses of antigens are only inhibited by the ~ strain 13 BPO-BGG antiserum which also inhibits immunized strain 13 (Table IV) cells but not high dose-immunized strain 2 cells (Table III) . Accordingly, it is likely that strain 2 and 13 produce different sets of antibodies against BPO-BGG with different idiotypic determinants. Inhibition of lymphocyte proliferation by anti-idiotypic antibodies is therefore likely to involve different clones of immune lymphoid cells. Experiments on the heterogeneity of anti-BPO-BGG antibodies ate in progress.
Preliminary evidence suggests that the inhibitory activity of the anti-idiotype sera is predominantly associated with the 19S fraction. It would appear therefore that these antisera (even when obtained from animals 4 mo after immunization; results not shown) are IgM-like and in this respect perhaps similar to the anti-idiotypic antibody raised in Lewis x Brown Norway F1 rats immunized with Lewis anti-BN alloantibody (reference 23 and F. W. Fitch, personal communication). Our anti-idiotype sera appear therefore to differ from the antiidiotypic antibodies of Eichmann (14) produced in guinea pigs against the A/J antibodies specific for the Group A streptococcal carbohydrate. The IgG~ fraction from the guinea pig anti-idiotypic serum injected into normal A/J mice can induce both T-and B-cell memory against the Group A streptococcal carbohydrate and prime both T and B lymphocytes for a secondary immune response to this antigen (24) . On the other hand, guinea pig IgG2 can suppress in vivo antibody production to streptococcal carbohydrate in mice presumably by the elimination of specific precursor cells (14) .
Obviously, the production and specificity of anti-idiotypic antisera against the individual's own idiotypes (possibly functioning as antigen receptors) may have important implications for antigen recognition and the regulation of the immune response in vitro and possible also in vivo. Studies on the in vivo effects of these sera are currently in progress.
Summary
The in vitro T-cell proliferation induced by penicilloylated bovine IgG (BPO-BGG) in sensitized strain 2 and strain 13 guinea pigs could be specifically blocked by strain-specific antisera presumably directed against cell membraneassociated immunoglobulin idiotypes. The anti-idiotypic antisera were prepared in strain 2 and strain 13 guinea pigs against immunoadsorbent purified anti-BPO-BGG antibodies which had been raised in strain 2 and strain 13 animals. Strain 13 antistrain 13 anti-BPO-BGG (4 strain 13 BPO-BGG) suppressed the in vitro BPO-BGG response of cells from immunized strain 13 animals but did not inhibit the response of cells from immune strain 2 animals. Conversely, the corresponding antiserum raised in a strain 2 combination (4 strain 2 BPO-BGG) only inhibited the in vitro BPO-BGG response of strain 2 cells. Furthermore, the inhibitory activity of the antisera could only be absorbed by immune cells from the syngeneic strain. The activity of the ~ strain 13 BPO-BGG serum was highly specific; the inhibitory activity could only be absorbed by BPO-BGG-sensitive strain 13 cells. The inhibitory activity of the anti-idiotypic sera was predominantly associated with the 19S fraction. The data suggest that immune cells and in particular T lymphocytes from strain 2 and strain 13 guinea pigs possess strain-specific recognition structures for BPO-BGG with the same idiotypes as the corresponding strain-specific immunoglobulins. Furthermore, the production of such inhibitory anti-idiotypic sera was restricted to syngeneic combinations, which suggests a potential role of autoanti-idiotypic antibodies in the regulation of the immune response. The anti-idiotypic antisera used here are apparently directed against gene products not associated with the strain 2 or strain 13 major histocompatibility complex.
